Drug Patent Expirations in May 2013

Drug Patent Expirations for May 2013

TradenameApplicantGeneric NamePatent NumberPatent Expiration
HUMALOG PENLillyinsulin lispro recombinant5,514,646May 7, 2013
GEMZARLillygemcitabine hydrochloride5,464,826*PEDMay 7, 2013
HUMALOG MIX 50/50 KWIKPENLillyinsulin lispro protamine recombinant; insulin lispro recombinant5,514,646May 7, 2013
HUMALOG MIX 75/25 KWIKPENLillyinsulin lispro protamine recombinant; insulin lispro recombinant5,514,646May 7, 2013
HUMALOG KWIKPENLillyinsulin lispro recombinant5,514,646May 7, 2013
PREVACIDTakeda Pharms Usalansoprazole5,464,632*PEDMay 7, 2013
HUMALOG MIX 50/50Lillyinsulin lispro protamine recombinant; insulin lispro recombinant5,514,646May 7, 2013
HUMALOG MIX 75/25Lillyinsulin lispro protamine recombinant; insulin lispro recombinant5,514,646May 7, 2013
HUMALOGLillyinsulin lispro recombinant5,514,646May 7, 2013
ZAVESCAActelion Pharms Ltdmiglustat5,472,969May 13, 2013
DEPOCYTPacira Pharms Inccytarabine5,455,044May 14, 2013
ZOMIGIprzolmitriptan5,466,699*PEDMay 14, 2013
ZOMIG-ZMTAstrazenecazolmitriptan5,466,699*PEDMay 14, 2013
ZOMIGIprzolmitriptan5,863,935*PEDMay 14, 2013
ZOMIGAstrazenecazolmitriptan5,466,699*PEDMay 14, 2013
OSMOPREPSalix Pharmssodium phosphate, dibasic, anhydrous; sodium phosphate, monobasic, monohydrate5,616,346May 18, 2013
VISICOLSalix Pharmssodium phosphate, dibasic anhydrous; sodium phosphate, monobasic, monohydrate5,616,346May 18, 2013
ADRENACLICKAmedra Pharmsepinephrine5,665,071May 27, 2013
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.

Subscribers have access to valuable datasets, including:

  • Clinical trial information
  • International patent families
  • International patent priority and PCT information
  • Patent maintenance
  • Full-text patent downloads
  • Sales data (top 200 drugs)
  • Paragraph IV challenges
  • Tentative approvals
  • Dynamic search capabilities with data export
  • More…
See the Database Preview and Plan Comparison.
Contact Us with any questions.

Comments are closed.

Do NOT follow this link or you will be banned from the site!
%d bloggers like this: